Suppliers / Alaina Healthcare

Alaina Healthcare

India 97 employees Updated 9 July 2026

Alaina Healthcare is a finished-dose manufacturer based in India. It appears in 6 regulatory filings across 1 regulator, without an active US DMF or CEP on file. Its GMP standing is certified by US FDA. Its most recent recorded inspection, by US FDA, closed on 3 May 2024 as VAI. Customs aggregates show $1.1M of exports covering 163 molecules to 1 destination in 2025.

0
active US DMFs
0
valid CEPs
1
registered plants 1 with an FDA FEI number
6
filings across 1 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026.

Inspection history

  • 3 May 2024 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Baddi, India 3013950309

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 6 None
US FDA None 1

Scale

Year Revenue Exports Destinations
2026 YTD Not reported $35K 1
2025 Not reported $1.1M 1
2024 Not reported $1.5M 1
2023 Not reported $913K 2

Export figures are customs aggregates. We do not publish the identity of any buyer.

Comparing suppliers?

Choose your molecules and target markets. Alaina Healthcare comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 3 May 2024.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Customs aggregates
Export values, molecule and destination counts